The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines

By Nichol K.L.  

Vaccine, Vol. 21, Iss. 16, 2003-05 ,pp. : 1769-1775

Elsevier

Access to resources Recommend Favorite

Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study

By Gorse G.J.   O'Connor T.Z.   Young S.L.   Mendelman P.M.   Bradley S.F.   Nichol K.L.   Strickland J.H.   Paulson D.M.   Rice K.L.   Foster R.A.   Fulambarker A.M.   Shigeoka J.W.   Kuschner W.G.   Goodman R.P.   Neuzil K.M.   Wittes J.   Boardman K.D.   Peduzzi P.N.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2142-2153

Elsevier

Access to resources Recommend Favorite

Protection against influenza B virus infection by immunization with DNA vaccines

By Chen Z.   Kadowaki S.-e.   Hagiwara Y.   Yoshikawa T.   Sata T.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1446-1455

Elsevier

Access to resources Recommend Favorite

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice

By Takada A.   Matsushita S.   Ninomiya A.   Kawaoka Y.   Kida H.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3212-3218

Elsevier

Access to resources Recommend Favorite

Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus

By Wu C.-N.   Lin Y.-C.   Fann C.   Liao N.-S.   Shih S.-R.   Ho M.-S.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 895-904

Elsevier

Access to resources Recommend Favorite